BeStock  
Stocks › Biotechnology › ARDX

Ardelyx ARDX

US equityMarket cap rank #3341Biotechnology
$2.99 −$0.07 (-2.29%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $2.99 0.00%
Open$3.01
Prev close$3.06
Day range$2.95 – $3.08
Volume6.20M
Market cap$751.60M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership72.1%-0.50 pts vs. prior quarter
Institutions holding282-11 vs. prior quarter
Insider trades (recent)16 buys / 32 sellsNet selling
Short interest11.31% of floatDays to cover 7.5 · as of 30 Oct 2026
Short-sale volume share18.5%5-day average of daily volume

Short-sale volume as % of daily volume

11%17%23%29%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$2.71M (10 inflow days, 10 outflow days).

Net flow by order size, last 20 sessions

−$1.9MSuper−$818.6KBig−$4.0MMid−$3.3MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 32.7% of shares outstanding.

Largest holders

  • BlackRock11.28%
  • Rubric Capital Management LP6.45%
  • Millennium Management LLC5.53%
  • State Street Global Advisors5.27%
  • Vanguard Capital Management, LLC4.16%
  • Macquarie Investment Management Business Trust3.80%
  • Vanguard Portfolio Management, LLC3.17%
  • Geode Capital Management, LLC2.47%

By investor type

  • Mutual Fund46.28%
  • Hedge Fund19.65%
  • Public Company3.55%
  • Individual/Insider3.35%
  • Insurance Company1.06%
  • Private Company1.00%
  • Government Pension Fund0.42%
  • Family Office/Trust0.13%

Reported short interest has risen from 8.69% to 11.31% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
BlackRock Mutual Fund 2026/Q3 +4,861,950 11.3%
Invesco Capital Management LLC Mutual Fund 2026/Q3 +2,025,124 1.3%
UBS Asset Management Mutual Fund 2026/Q3 +1,259,827 0.9%
Citigroup Inc. Public Company 2026/Q3 +1,052,215 0.5%
Mackenzie Financial Corporation Mutual Fund 2026/Q3 +419,549 0.4%
Morgan Stanley Public Company 2026/Q3 +196,081 1.0%
Creative Planning, Inc. Mutual Fund 2026/Q3 +183,936 0.1%
Squarepoint OPS LLC Hedge Fund 2026/Q3 +127,402 0.3%
Hennion & Walsh Asset Management, Inc. Mutual Fund 2026/Q3 +127,159 0.5%
Rubric Capital Management LP Hedge Fund 2026/Q3 +14,341,804 6.4%
Aigh Capital Management, LLC Hedge Fund 2026/Q3 +3,200,000 1.3%
BlackRock Mutual Fund 2026/Q3 +2,340,498 9.4%
Macquarie Investment Management Business Trust Mutual Fund 2026/Q3 +1,377,363 3.8%
Vanguard Portfolio Management, LLC Mutual Fund 2026/Q3 +1,365,081 3.2%
Invesco Capital Management LLC Mutual Fund 2026/Q3 +1,045,994 0.5%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
20 Aug 2026 Michael Raab Chief Executive Officer Private Disposition -58,574 $3.86 1,645,156
20 Aug 2026 John Bishop Private Disposition -19,750 $3.86 317,095
20 Aug 2026 James Brady Chief Human Resources Officer Private Disposition -15,136 $3.86 245,930
20 Aug 2026 Laura Williams Chief Patient Officer Emeritus Private Disposition -10,739 $3.86 367,456
20 Aug 2026 Eric Foster Former Chief Commercial Officer Private Disposition -8,562 $3.86 409,410
20 Aug 2026 Mike Kelliher Chief Business Officer Private Disposition -7,758 $3.86 349,660
20 Aug 2026 Joseph Reilly Senior VP of Finance & Principal Accounting Officer Private Disposition -3,982 $3.86 145,854
20 Aug 2026 Sue Hohenleitner Chief Financial Officer Private Disposition -1,558 $3.86 227,520
14 Jul 2026 Michael Raab Chief Executive Officer Automatic Disposition -20,834 $5.06 1,703,730
14 Jul 2026 Michael Raab Chief Executive Officer Derivative Exercise and Sale -20,834 $5.06 1,703,730
17 Jun 2026 Laura Williams Chief Patient Officer Emeritus Automatic Disposition -50,898 $5.99 378,195
17 Jun 2026 Laura Williams Chief Patient Officer Emeritus Derivative Exercise and Sale -31,000 $5.99 378,195
15 Jun 2026 David Mott Independent Chairperson Other Acquisition +20,282 – 3,312,812
15 Jun 2026 David Mott Independent Chairperson Other Acquisition +26,455 – 36,843
15 Jun 2026 David Mott Independent Chairperson Other Derivative Acquisition +39,715 $5.67 39,715
15 Jun 2026 Robert Bazemore Independent Director Other Acquisition +26,455 – 36,842
15 Jun 2026 Robert Bazemore Independent Director Other Derivative Acquisition +39,715 $5.67 39,715
15 Jun 2026 William Charles Bertrand Independent Director Other Acquisition +12,345 – 292,664
15 Jun 2026 William Charles Bertrand Independent Director Other Acquisition +26,455 – 36,843
15 Jun 2026 William Charles Bertrand Independent Director Other Derivative Acquisition +39,715 $5.67 39,715

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 29,205,209 11.3% 7.5
15 Oct 2026 30,237,216 11.7% 6.5
30 Sep 2026 27,676,626 10.7% 6.6
15 Sep 2026 25,602,541 9.9% 6.3
31 Aug 2026 22,716,201 8.8% 6.1
14 Aug 2026 22,433,157 8.7% 3.3

Discussion

No comments yet — be the first to weigh in on ARDX.

Sign in to join the discussion.

Scroll to Top